Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Predict + Protect: A Randomized Controlled Trial Exploring the Effectiveness of a Predictive Health Education Intervention on the Adoption of Protective Behaviors Related to Influenza-like Illness (ILI)

NCT06229444 is registered in ClinicalTrials.gov with Evidation Health as lead sponsor.

NCT NCT06229444
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06229444 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Predict + Protect: A Randomized Controlled Trial Exploring the Effectiveness of a Predictive Health Education Intervention on the Adoption of Protective Behaviors Related to Influenza-like Illness (ILI)
Lead sponsor
Evidation Health
Phase
Not applicable
Overall status
Completed
Start date
February 12, 2024
Completion date
September 6, 2024
Enrollment
17,043 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19, influenza, influenza a, influenza b, respiratory syncytial virus (rsv)